Re: A comment about market penetration
in response to
by
posted on
Mar 19, 2017 01:16PM
sumpup, I am probably banned from Agora but I cannot help but repsond.
Who are you and can you tell us more?
bfw's post (I should say posts) provided incredible practical insight of the implications of success with this drug (apabetalone) and if everyone references slide 32 of the Cowen presentation you will get another aspect of the payer aspect of this compound...very positive in competitive terms but I would really like to have an expert give a full, idiot proof, definition of that table for people like me...speficically NNT - number needed to treat/year.
Thanks for your post and as well bfw and BDAZ!
Toinv